The study met its prespecified primary endpoint of demonstrating a statistically significant slowing of disease progression as measured by the composite Unified Huntington’s Disease Rating Scale (cUHDRS) at 36 months. The post Gene Therapy Significantly Slows Huntington Disease Progression appeared first on GEN - Genetic Engineering and Biotechnology News.
